Bioequivalence Study of Amoxicillin 400 mg/Clavulanic Acid 57 mg Chewable Tablets Under Fasting Conditions
NCT00778661
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
40
Enrollment
INDUSTRY
Sponsor class
Conditions
Healthy
Interventions
DRUG:
amoxicillin 400mg + clovalunic acid 57.5mg tablets
Sponsor
Ranbaxy Laboratories Limited